nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—HTR1B—cranial nerve—salivary gland cancer	0.0348	0.143	CbGeAlD
Risperidone—HTR1D—cranial nerve—salivary gland cancer	0.0337	0.139	CbGeAlD
Risperidone—HTR7—cranial nerve—salivary gland cancer	0.0268	0.111	CbGeAlD
Risperidone—HTR2A—cranial nerve—salivary gland cancer	0.0167	0.069	CbGeAlD
Risperidone—H1F0—neck—salivary gland cancer	0.0125	0.0516	CbGeAlD
Risperidone—H1F0—parotid gland—salivary gland cancer	0.0102	0.042	CbGeAlD
Risperidone—H1F0—saliva-secreting gland—salivary gland cancer	0.00976	0.0402	CbGeAlD
Risperidone—H1F0—connective tissue—salivary gland cancer	0.00896	0.037	CbGeAlD
Risperidone—HTR7—neck—salivary gland cancer	0.00772	0.0318	CbGeAlD
Risperidone—HTR1D—connective tissue—salivary gland cancer	0.00694	0.0286	CbGeAlD
Risperidone—H1F0—lymphoid tissue—salivary gland cancer	0.00655	0.027	CbGeAlD
Risperidone—ADRA2C—parotid gland—salivary gland cancer	0.00578	0.0238	CbGeAlD
Risperidone—HTR7—connective tissue—salivary gland cancer	0.00553	0.0228	CbGeAlD
Risperidone—HTR7—epithelium—salivary gland cancer	0.00525	0.0217	CbGeAlD
Risperidone—ADRA1A—epithelium—salivary gland cancer	0.00507	0.0209	CbGeAlD
Risperidone—HTR2A—neck—salivary gland cancer	0.00481	0.0199	CbGeAlD
Risperidone—HRH1—connective tissue—salivary gland cancer	0.00413	0.017	CbGeAlD
Risperidone—ADRA2A—connective tissue—salivary gland cancer	0.00406	0.0167	CbGeAlD
Risperidone—HRH1—epithelium—salivary gland cancer	0.00392	0.0162	CbGeAlD
Risperidone—ADRA1A—lymphoid tissue—salivary gland cancer	0.0039	0.0161	CbGeAlD
Risperidone—H1F0—lymph node—salivary gland cancer	0.0037	0.0153	CbGeAlD
Risperidone—HTR2A—connective tissue—salivary gland cancer	0.00345	0.0142	CbGeAlD
Risperidone—HTR2A—epithelium—salivary gland cancer	0.00327	0.0135	CbGeAlD
Risperidone—HTR2B—lymph node—salivary gland cancer	0.00266	0.011	CbGeAlD
Risperidone—ABCB1—epithelium—salivary gland cancer	0.00215	0.00885	CbGeAlD
Risperidone—KCNH2—lymph node—salivary gland cancer	0.00213	0.00877	CbGeAlD
Risperidone—ADRA2C—lymph node—salivary gland cancer	0.0021	0.00865	CbGeAlD
Risperidone—HRH1—lymph node—salivary gland cancer	0.0017	0.00703	CbGeAlD
Risperidone—ADRA2A—lymph node—salivary gland cancer	0.00167	0.0069	CbGeAlD
Risperidone—ABCB1—lymphoid tissue—salivary gland cancer	0.00165	0.00682	CbGeAlD
Risperidone—ABCB1—lymph node—salivary gland cancer	0.000933	0.00385	CbGeAlD
Risperidone—CYP2D6—Metabolism—VCAN—salivary gland cancer	0.000143	0.000189	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MAP2K2—salivary gland cancer	0.000143	0.000189	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—FGFR4—salivary gland cancer	0.000143	0.000188	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MAP2K2—salivary gland cancer	0.000141	0.000186	CbGpPWpGaD
Risperidone—ADRA2B—Hemostasis—PIK3CA—salivary gland cancer	0.000141	0.000186	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—FBXW7—salivary gland cancer	0.00014	0.000185	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PHGDH—salivary gland cancer	0.000136	0.00018	CbGpPWpGaD
Risperidone—ADRA2B—Hemostasis—TP53—salivary gland cancer	0.000136	0.00018	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—NOTCH1—salivary gland cancer	0.000136	0.00018	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—NOTCH1—salivary gland cancer	0.000135	0.000179	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—NOTCH1—salivary gland cancer	0.000132	0.000175	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—FOXO3—salivary gland cancer	0.000132	0.000175	CbGpPWpGaD
Risperidone—ADRA2C—Hemostasis—PIK3CA—salivary gland cancer	0.000132	0.000174	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	0.000131	0.000173	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—NOTCH1—salivary gland cancer	0.00013	0.000172	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—FOXO3—salivary gland cancer	0.00013	0.000172	CbGpPWpGaD
Risperidone—ADRA2B—Hemostasis—HRAS—salivary gland cancer	0.00013	0.000172	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—FOXO3—salivary gland cancer	0.00013	0.000172	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—FOXO3—salivary gland cancer	0.000128	0.000168	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MAP2K2—salivary gland cancer	0.000128	0.000168	CbGpPWpGaD
Risperidone—ADRA2C—Hemostasis—TP53—salivary gland cancer	0.000127	0.000168	CbGpPWpGaD
Risperidone—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000127	0.000168	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—NOTCH1—salivary gland cancer	0.000124	0.000164	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—CREBBP—salivary gland cancer	0.000123	0.000163	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MAP2K2—salivary gland cancer	0.000123	0.000163	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—CREBBP—salivary gland cancer	0.000123	0.000162	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MAP2K2—salivary gland cancer	0.000122	0.000162	CbGpPWpGaD
Risperidone—ADRA2C—Hemostasis—HRAS—salivary gland cancer	0.000122	0.000161	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—CREBBP—salivary gland cancer	0.00012	0.000158	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MAP2K2—salivary gland cancer	0.000119	0.000157	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—AQP1—salivary gland cancer	0.000119	0.000157	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—FOXO3—salivary gland cancer	0.000119	0.000156	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—CREBBP—salivary gland cancer	0.000118	0.000156	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—NOTCH1—salivary gland cancer	0.000117	0.000155	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MAP2K2—salivary gland cancer	0.000117	0.000155	CbGpPWpGaD
Risperidone—HTR7—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000116	0.000153	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—NOTCH1—salivary gland cancer	0.000116	0.000153	CbGpPWpGaD
Risperidone—HTR1D—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000115	0.000152	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CREBBP—salivary gland cancer	0.000113	0.000149	CbGpPWpGaD
Risperidone—HTR1B—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000113	0.000149	CbGpPWpGaD
Risperidone—DRD4—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000111	0.000146	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—CREBBP—salivary gland cancer	0.000109	0.000144	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MAP2K2—salivary gland cancer	0.000108	0.000143	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—PIK3CA—salivary gland cancer	0.000107	0.000141	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MAP2K2—salivary gland cancer	0.000106	0.00014	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CREBBP—salivary gland cancer	0.000106	0.00014	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MAP2K2—salivary gland cancer	0.000106	0.00014	CbGpPWpGaD
Risperidone—HTR2B—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000106	0.00014	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—CREBBP—salivary gland cancer	0.000106	0.00014	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000105	0.000139	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CREBBP—salivary gland cancer	0.000105	0.000139	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000105	0.000138	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—NOTCH1—salivary gland cancer	0.000104	0.000138	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MAP2K2—salivary gland cancer	0.000104	0.000137	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—TP53—salivary gland cancer	0.000103	0.000136	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000102	0.000135	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—NOTCH1—salivary gland cancer	0.000101	0.000133	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000101	0.000133	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—NOTCH1—salivary gland cancer	0.0001	0.000132	CbGpPWpGaD
Risperidone—DRD1—GPCR downstream signaling—PIK3CA—salivary gland cancer	9.99e-05	0.000132	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—HRAS—salivary gland cancer	9.88e-05	0.00013	CbGpPWpGaD
Risperidone—DRD3—GPCR downstream signaling—PIK3CA—salivary gland cancer	9.86e-05	0.00013	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—NOTCH1—salivary gland cancer	9.76e-05	0.000129	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—HRAS—salivary gland cancer	9.74e-05	0.000129	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MAP2K2—salivary gland cancer	9.68e-05	0.000128	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—HRAS—salivary gland cancer	9.67e-05	0.000128	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—PIK3CA—salivary gland cancer	9.62e-05	0.000127	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—NOTCH1—salivary gland cancer	9.61e-05	0.000127	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CREBBP—salivary gland cancer	9.47e-05	0.000125	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—HRAS—salivary gland cancer	9.47e-05	0.000125	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—NUP62—salivary gland cancer	9.45e-05	0.000125	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—VCAN—salivary gland cancer	9.37e-05	0.000124	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—HRAS—salivary gland cancer	9.32e-05	0.000123	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CREBBP—salivary gland cancer	9.15e-05	0.000121	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—CCND1—salivary gland cancer	9.13e-05	0.000121	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CREBBP—salivary gland cancer	9.1e-05	0.00012	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—CCND1—salivary gland cancer	9.07e-05	0.00012	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—PIK3CA—salivary gland cancer	9.07e-05	0.00012	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—PIK3CA—salivary gland cancer	8.95e-05	0.000118	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—HRAS—salivary gland cancer	8.9e-05	0.000117	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—PIK3CA—salivary gland cancer	8.9e-05	0.000117	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—CCND1—salivary gland cancer	8.88e-05	0.000117	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—NOTCH1—salivary gland cancer	8.86e-05	0.000117	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CREBBP—salivary gland cancer	8.85e-05	0.000117	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—PTEN—salivary gland cancer	8.81e-05	0.000116	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—PTEN—salivary gland cancer	8.76e-05	0.000116	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—CCND1—salivary gland cancer	8.74e-05	0.000115	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—NOTCH1—salivary gland cancer	8.71e-05	0.000115	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CREBBP—salivary gland cancer	8.71e-05	0.000115	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—NOTCH1—salivary gland cancer	8.7e-05	0.000115	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—CREBBP—salivary gland cancer	8.6e-05	0.000113	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—PIK3CA—salivary gland cancer	8.59e-05	0.000113	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—PTEN—salivary gland cancer	8.57e-05	0.000113	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—PIK3CA—salivary gland cancer	8.55e-05	0.000113	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—NOTCH1—salivary gland cancer	8.53e-05	0.000113	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—PTEN—salivary gland cancer	8.44e-05	0.000111	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—EP300—salivary gland cancer	8.41e-05	0.000111	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—HRAS—salivary gland cancer	8.39e-05	0.000111	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—EP300—salivary gland cancer	8.35e-05	0.00011	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CCND1—salivary gland cancer	8.34e-05	0.00011	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—PIK3CA—salivary gland cancer	8.31e-05	0.00011	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—HRAS—salivary gland cancer	8.28e-05	0.000109	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—PIK3CA—salivary gland cancer	8.18e-05	0.000108	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—EP300—salivary gland cancer	8.18e-05	0.000108	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—PIK3CA—salivary gland cancer	8.08e-05	0.000107	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—PTEN—salivary gland cancer	8.05e-05	0.000106	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—EP300—salivary gland cancer	8.05e-05	0.000106	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CREBBP—salivary gland cancer	8.03e-05	0.000106	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—NOTCH1—salivary gland cancer	7.93e-05	0.000105	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CREBBP—salivary gland cancer	7.9e-05	0.000104	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CREBBP—salivary gland cancer	7.88e-05	0.000104	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—CREBBP—salivary gland cancer	7.88e-05	0.000104	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CCND1—salivary gland cancer	7.87e-05	0.000104	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—PIK3CA—salivary gland cancer	7.8e-05	0.000103	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—PTEN—salivary gland cancer	7.78e-05	0.000103	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CCND1—salivary gland cancer	7.76e-05	0.000102	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—PIK3CA—salivary gland cancer	7.76e-05	0.000102	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CREBBP—salivary gland cancer	7.74e-05	0.000102	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—EP300—salivary gland cancer	7.68e-05	0.000101	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—PTEN—salivary gland cancer	7.6e-05	0.0001	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—PTEN—salivary gland cancer	7.56e-05	9.98e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—PIK3CA—salivary gland cancer	7.55e-05	9.96e-05	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—PIK3CA—salivary gland cancer	7.54e-05	9.95e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—PTEN—salivary gland cancer	7.49e-05	9.89e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—HRAS—salivary gland cancer	7.48e-05	9.87e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—PIK3CA—salivary gland cancer	7.43e-05	9.81e-05	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—EP300—salivary gland cancer	7.42e-05	9.8e-05	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—PIK3CA—salivary gland cancer	7.42e-05	9.79e-05	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—PIK3CA—salivary gland cancer	7.4e-05	9.77e-05	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—PIK3CA—salivary gland cancer	7.27e-05	9.59e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—EP300—salivary gland cancer	7.24e-05	9.56e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—HRAS—salivary gland cancer	7.22e-05	9.53e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—EP300—salivary gland cancer	7.21e-05	9.51e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CREBBP—salivary gland cancer	7.19e-05	9.49e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—HRAS—salivary gland cancer	7.18e-05	9.48e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—EP300—salivary gland cancer	7.15e-05	9.43e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CCND1—salivary gland cancer	7.01e-05	9.25e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—HRAS—salivary gland cancer	6.98e-05	9.22e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—HRAS—salivary gland cancer	6.87e-05	9.07e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—PIK3CA—salivary gland cancer	6.85e-05	9.04e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CCND1—salivary gland cancer	6.77e-05	8.93e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—PTEN—salivary gland cancer	6.77e-05	8.93e-05	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—PIK3CA—salivary gland cancer	6.75e-05	8.91e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—PIK3CA—salivary gland cancer	6.74e-05	8.89e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CCND1—salivary gland cancer	6.73e-05	8.89e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—PIK3CA—salivary gland cancer	6.72e-05	8.88e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—PIK3CA—salivary gland cancer	6.6e-05	8.71e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CCND1—salivary gland cancer	6.55e-05	8.64e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—PTEN—salivary gland cancer	6.53e-05	8.62e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—PTEN—salivary gland cancer	6.5e-05	8.58e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—EP300—salivary gland cancer	6.45e-05	8.52e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CCND1—salivary gland cancer	6.44e-05	8.51e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—HRAS—salivary gland cancer	6.34e-05	8.36e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—PTEN—salivary gland cancer	6.32e-05	8.34e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—HRAS—salivary gland cancer	6.23e-05	8.23e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—EP300—salivary gland cancer	6.23e-05	8.22e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—HRAS—salivary gland cancer	6.22e-05	8.21e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—PTEN—salivary gland cancer	6.22e-05	8.21e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—PIK3CA—salivary gland cancer	6.22e-05	8.21e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—EP300—salivary gland cancer	6.2e-05	8.18e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—PIK3CA—salivary gland cancer	6.18e-05	8.15e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PTEN—salivary gland cancer	6.14e-05	8.1e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—PIK3CA—salivary gland cancer	6.13e-05	8.09e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—HRAS—salivary gland cancer	6.1e-05	8.06e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—PIK3CA—salivary gland cancer	6.05e-05	7.98e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—EP300—salivary gland cancer	6.03e-05	7.96e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TP53—salivary gland cancer	6.02e-05	7.94e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TP53—salivary gland cancer	5.98e-05	7.89e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—PIK3CA—salivary gland cancer	5.95e-05	7.86e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CREBBP—salivary gland cancer	5.94e-05	7.85e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CCND1—salivary gland cancer	5.94e-05	7.84e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—EP300—salivary gland cancer	5.93e-05	7.83e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—EP300—salivary gland cancer	5.85e-05	7.73e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TP53—salivary gland cancer	5.85e-05	7.72e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CCND1—salivary gland cancer	5.85e-05	7.72e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CCND1—salivary gland cancer	5.83e-05	7.7e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TP53—salivary gland cancer	5.76e-05	7.6e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—HRAS—salivary gland cancer	5.75e-05	7.59e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PTEN—salivary gland cancer	5.73e-05	7.57e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CCND1—salivary gland cancer	5.72e-05	7.56e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—HRAS—salivary gland cancer	5.72e-05	7.54e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—PIK3CA—salivary gland cancer	5.68e-05	7.5e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—HRAS—salivary gland cancer	5.67e-05	7.49e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PTEN—salivary gland cancer	5.64e-05	7.45e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PTEN—salivary gland cancer	5.63e-05	7.43e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PTEN—salivary gland cancer	5.63e-05	7.43e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CREBBP—salivary gland cancer	5.6e-05	7.39e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—HRAS—salivary gland cancer	5.6e-05	7.39e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PTEN—salivary gland cancer	5.53e-05	7.29e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—HRAS—salivary gland cancer	5.51e-05	7.27e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TP53—salivary gland cancer	5.5e-05	7.26e-05	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—PIK3CA—salivary gland cancer	5.49e-05	7.25e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—EP300—salivary gland cancer	5.47e-05	7.22e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—EP300—salivary gland cancer	5.38e-05	7.1e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—EP300—salivary gland cancer	5.37e-05	7.09e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—EP300—salivary gland cancer	5.37e-05	7.08e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—PIK3CA—salivary gland cancer	5.36e-05	7.07e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—PIK3CA—salivary gland cancer	5.33e-05	7.04e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CCND1—salivary gland cancer	5.32e-05	7.02e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—PIK3CA—salivary gland cancer	5.29e-05	6.98e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—EP300—salivary gland cancer	5.27e-05	6.96e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—HRAS—salivary gland cancer	5.26e-05	6.94e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TP53—salivary gland cancer	5.18e-05	6.84e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PTEN—salivary gland cancer	5.13e-05	6.78e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TP53—salivary gland cancer	5.11e-05	6.75e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—HRAS—salivary gland cancer	4.96e-05	6.54e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—EP300—salivary gland cancer	4.9e-05	6.46e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—HRAS—salivary gland cancer	4.89e-05	6.46e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—PIK3CA—salivary gland cancer	4.77e-05	6.3e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TP53—salivary gland cancer	4.62e-05	6.1e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—PIK3CA—salivary gland cancer	4.61e-05	6.08e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—PIK3CA—salivary gland cancer	4.58e-05	6.05e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—PIK3CA—salivary gland cancer	4.46e-05	5.89e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TP53—salivary gland cancer	4.46e-05	5.88e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TP53—salivary gland cancer	4.43e-05	5.85e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—HRAS—salivary gland cancer	4.42e-05	5.83e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—PIK3CA—salivary gland cancer	4.39e-05	5.79e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PIK3CA—salivary gland cancer	4.33e-05	5.72e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TP53—salivary gland cancer	4.31e-05	5.69e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—HRAS—salivary gland cancer	4.26e-05	5.63e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PTEN—salivary gland cancer	4.25e-05	5.6e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TP53—salivary gland cancer	4.25e-05	5.6e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—HRAS—salivary gland cancer	4.24e-05	5.6e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—HRAS—salivary gland cancer	4.13e-05	5.45e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—HRAS—salivary gland cancer	4.06e-05	5.36e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—EP300—salivary gland cancer	4.05e-05	5.34e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PIK3CA—salivary gland cancer	4.05e-05	5.34e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PTEN—salivary gland cancer	4e-05	5.28e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PIK3CA—salivary gland cancer	3.98e-05	5.25e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PIK3CA—salivary gland cancer	3.97e-05	5.24e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PIK3CA—salivary gland cancer	3.97e-05	5.24e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TP53—salivary gland cancer	3.91e-05	5.17e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PIK3CA—salivary gland cancer	3.9e-05	5.14e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TP53—salivary gland cancer	3.85e-05	5.08e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TP53—salivary gland cancer	3.84e-05	5.07e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—EP300—salivary gland cancer	3.82e-05	5.04e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TP53—salivary gland cancer	3.77e-05	4.98e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—HRAS—salivary gland cancer	3.74e-05	4.94e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—HRAS—salivary gland cancer	3.68e-05	4.86e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—HRAS—salivary gland cancer	3.67e-05	4.85e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CREBBP—salivary gland cancer	3.66e-05	4.83e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PIK3CA—salivary gland cancer	3.62e-05	4.78e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—HRAS—salivary gland cancer	3.61e-05	4.76e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TP53—salivary gland cancer	3.5e-05	4.62e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—HRAS—salivary gland cancer	3.35e-05	4.42e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PIK3CA—salivary gland cancer	2.99e-05	3.95e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PIK3CA—salivary gland cancer	2.82e-05	3.73e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PTEN—salivary gland cancer	2.62e-05	3.45e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—EP300—salivary gland cancer	2.49e-05	3.29e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	1.85e-05	2.44e-05	CbGpPWpGaD
